收藏切换
Clinical study of the Jiedu granule combined with transcatheter arterial chemoembolization and gamma knife surgery in the treatment of the hepatocellular carcinoma with portal vein tumor thrombus
收藏切换
Hai-yuan-bo GUO1, Huang-ming CAO2, Wei HUANG2, Xiao-lan YIN3, Yin WU2, Jun ZHOU2, *
World Clinical Drug | 2018, 39(1) : 24 - 28
Less
收藏切换
World Clinical Drug | 2018, 39(1): 24-28
• Article •
Clinical study of the Jiedu granule combined with transcatheter arterial chemoembolization and gamma knife surgery in the treatment of the hepatocellular carcinoma with portal vein tumor thrombus
Full
Hai-yuan-bo GUO1, Huang-ming CAO2, Wei HUANG2, Xiao-lan YIN3, Yin WU2, Jun ZHOU2, *
Affiliations
  • 1.Department of Oncology, The Second People's Hospital of Pinghu, Pinghu 314201
  • 2.Department of Oncology, Shanghai East Hospital, Tongji University, Shanghai 200120
  • 3.Centre of Gamma Knife, The 411st Hospital of Chinese People’s Liberation Army, Shanghai 200081, China
Published: 2018-01-10 doi: 10.13683/j.wph.2018.01.006
Outline
收藏切换
Objective

To observe the efficacy and safety of the Jiedu granule combined with transcatheter arterial chemoembolization (TACE) and gamma knife surgery on the hepatocellular carcinoma with portal vein tumor thrombus (PVTT).

Methods

Total 129 patients of hepatocellular carcinoma with PVTT were divided into trial group (n=66) and control group (n=63). TACE and gamma knife surgery were given to both groups, Jiedu granule (twice daily) was added to the trial group. The median survival time and cumulative survival rate were analyzed and the clinical adverse events were compared between two groups. The independent prognostic factors of patients were analyzed by Cox proportional hazard model.

Results

The 1-, 2- and 3-year cumulative survival rates were 45%, 23%, 17% in trial group and 21%, 10%, 8% in control group respectively. The median survival time was 0.7 and 5.4 months respectively. Survival analysis showed that the difference between the two groups was statistically significant (P<0.01). There were no significant differences in clinical adverse events between the two groups (P>0.05). The Cox proportional hazard model analysis showed that Child-Pugh classification was a risk factor for prognosis, while Jiedu granule was a protective factor.

Conclusion

Jiedu granule combined with TACE and gamma knife surgery can prolong the survival time of the hepatocellular carcinoma patients with PVTT, which is safe and well tolerated. The Jiedu granule is a protective factor to improve the prognosis of patients, and it can be widely used in clinic.

Jiedu granule  /  hepatocellular carcinoma  /  portal vein tumor thrombus  /  survival analysis
郭海渊博, 操黄明, 黄薇, 尹小兰, 吴寅, 周俊. 解毒颗粒联合经导管肝动脉化疗栓塞术与伽玛刀治疗原发性肝癌伴门静脉癌栓的临床研究. 世界临床药物, 2018 , 39 (1) : 24 -28 . DOI: 10.13683/j.wph.2018.01.006
Hai-yuan-bo GUO, Huang-ming CAO, Wei HUANG, Xiao-lan YIN, Yin WU, Jun ZHOU. Clinical study of the Jiedu granule combined with transcatheter arterial chemoembolization and gamma knife surgery in the treatment of the hepatocellular carcinoma with portal vein tumor thrombus[J]. World Clinical Drug, 2018 , 39 (1) : 24 -28 . DOI: 10.13683/j.wph.2018.01.006
Year 2018 volume 39 Issue 1
12
2
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2018.01.006
  • Receive Date:2017-09-26
  • Online Date:2026-11-19
  • Published:2018-01-10
Article Data
Affiliations
History
  • Received:2017-09-26
  • Revised:2017-11-21
Funding
Affiliations
    1.Department of Oncology, The Second People's Hospital of Pinghu, Pinghu 314201
    2.Department of Oncology, Shanghai East Hospital, Tongji University, Shanghai 200120
    3.Centre of Gamma Knife, The 411st Hospital of Chinese People’s Liberation Army, Shanghai 200081, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2018.01.006
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT